BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11394481)

  • 1. Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff--a postmarketing study.
    Saple DG; Ravichandran G; Desai A
    J Indian Med Assoc; 2000 Dec; 98(12):810-1. PubMed ID: 11394481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, open-label, non-comparative study of a combination of polytar and zinc pyrithione shampoo in the management of dandruff.
    Sawleshwarkar SN; Salgaonkar V; Oberai C
    Indian J Dermatol Venereol Leprol; 2004; 70(1):25-8. PubMed ID: 17642553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff.
    Schmidt-Rose T; Braren S; Fölster H; Hillemann T; Oltrogge B; Philipp P; Weets G; Fey S
    Int J Cosmet Sci; 2011 Jun; 33(3):276-82. PubMed ID: 21272039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment.
    Lorette G; Ermosilla V
    Eur J Dermatol; 2006; 16(5):558-64. PubMed ID: 17101479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea.
    Lee JH; Lee HS; Eun HC; Cho KH
    J Dermatolog Treat; 2003 Dec; 14(4):212-5. PubMed ID: 14660265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [1% econazole hair-shampoo in the treatment of pityriasis capitis; a comparative study versus zinc-pyrithione shampoo].
    Rigoni C; Toffolo P; Cantù A; Beretta D; Terenzio C
    G Ital Dermatol Venereol; 1989; 124(11-12):LXVII-LXX. PubMed ID: 2638641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis.
    Piérard-Franchimont C; Goffin V; Decroix J; Piérard GE
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):434-41. PubMed ID: 12476017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo.
    Warner RR; Schwartz JR; Boissy Y; Dawson TL
    J Am Acad Dermatol; 2001 Dec; 45(6):897-903. PubMed ID: 11712036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA; Goode K
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.
    Ratnavel RC; Squire RA; Boorman GC
    J Dermatolog Treat; 2007; 18(2):88-96. PubMed ID: 17520465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.
    Shin H; Kwon OS; Won CH; Kim BJ; Lee YW; Choe YB; Ahn KJ; Eun HC
    J Dermatol; 2009 Mar; 36(3):131-7. PubMed ID: 19335686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does tachyphylaxis occur in long-term management of scalp seborrheic dermatitis with pyrithione zinc-based treatments?
    Schwartz JR; Rocchetta H; Asawanonda P; Luo F; Thomas JH
    Int J Dermatol; 2009 Jan; 48(1):79-85. PubMed ID: 19126058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dandruff/seborrhoeic dermatitis is characterized by an inflammatory genomic signature and possible immune dysfunction: transcriptional analysis of the condition and treatment effects of zinc pyrithione.
    Mills KJ; Hu P; Henry J; Tamura M; Tiesman JP; Xu J
    Br J Dermatol; 2012 Jun; 166 Suppl 2():33-40. PubMed ID: 22670617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos.
    Draelos ZD; Kenneally DC; Hodges LT; Billhimer W; Copas M; Margraf C
    J Investig Dermatol Symp Proc; 2005 Dec; 10(3):201-4. PubMed ID: 16382664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of dandruff with 5% tea tree oil shampoo.
    Satchell AC; Saurajen A; Bell C; Barnetson RS
    J Am Acad Dermatol; 2002 Dec; 47(6):852-5. PubMed ID: 12451368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scalp stratum corneum histamine levels: novel sampling method reveals association with itch resolution in dandruff/seborrhoeic dermatitis treatment.
    Kerr K; Schwartz JR; Filloon T; Fieno A; Wehmeyer K; Szepietowski JC; Mills KJ
    Acta Derm Venereol; 2011 Jun; 91(4):404-8. PubMed ID: 21336476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pustular psoriasis and the Kobner phenomenon caused by allergic contact dermatitis from zinc pyrithione-containing shampoo.
    Jo JH; Jang HS; Ko HC; Kim MB; Oh CK; Kwon YW; Kwon KS
    Contact Dermatitis; 2005 Mar; 52(3):142-4. PubMed ID: 15811028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff.
    Danby FW; Maddin WS; Margesson LJ; Rosenthal D
    J Am Acad Dermatol; 1993 Dec; 29(6):1008-12. PubMed ID: 8245236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and skin tolerability of Saliker in the treatment of dandruff.
    Humke S; Budde MA; Ruzicka T; Richard A; Rougier A; Krutmann J
    Eur J Dermatol; 2002; 12(4):LII-LIII. PubMed ID: 12120604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.